SCHEMBL308875

SCHEMBL308875

Cc1ccc(-c2ccc(C(=O)O)cc2)cc1

nearest known ligand 0.85

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.85
SMN1; SMN2 Q16637 1/20 0.85
SRD5A2 P31213 2/20 0.74
RXRA P19793 4/20 0.72
RXRB P28702 4/20 0.72
BCL2L1 Q07817 1/20 0.60
BAD Q92934 1/20 0.60
TP53 P04637 1/20 0.60
TSHR P16473 1/20 0.60
MAP4K4 O95819 1/20 0.57
CES2 O00748 2/20 0.56
CES1 P23141 2/20 0.56
LMNA P02545 1/20 0.56
HSD17B10 Q99714 1/20 0.55
KDM4E B2RXH2 1/20 0.55
GAA P10253 1/20 0.55
MAPT P10636 1/20 0.55
HPGD P15428 1/20 0.55
MCL1 Q07820 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13888048 1.00 ALDH1A1 (0.85) ALDH1A1SMN1; SMN2SRD5A2RXRARXRB
SCHEMBL16103355 0.93 RXRA (0.77) ALDH1A1SMN1; SMN2SRD5A2RXRARXRB
SCHEMBL12446320 0.93 RXRA (0.77) ALDH1A1SMN1; SMN2SRD5A2RXRARXRB
Terephthalic Acid SCHEMBL15994097 0.92 ALDH1A1 (1.00) ALDH1A1SMN1; SMN2SRD5A2RXRARXRB
Terephthalic Acid SCHEMBL526449 0.92 ALDH1A1 (1.00) ALDH1A1SMN1; SMN2SRD5A2RXRARXRB
4-Methylbenzoic Acid SCHEMBL147465 0.92 ALDH1A1 (1.00) ALDH1A1SMN1; SMN2SRD5A2RXRARXRB
4-Methylbenzoic Acid SCHEMBL11366477 0.92 ALDH1A1 (1.00) ALDH1A1SMN1; SMN2SRD5A2RXRARXRB
4-Methylbenzoic Acid SCHEMBL93638 0.92 ALDH1A1 (1.00) ALDH1A1SMN1; SMN2SRD5A2RXRARXRB
4-Methylbenzoic Acid SCHEMBL1331178 0.92 ALDH1A1 (1.00) ALDH1A1SMN1; SMN2SRD5A2RXRARXRB
Biphenyl SCHEMBL28153557 0.91 ALDH1A1 (0.77) ALDH1A1SMN1; SMN2SRD5A2RXRARXRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 270 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220280494-A1 COMPOSITIONS FOR SMALL MOLECULE THERAPEUTIC AGENT COMPOUNDS DELPOR, INC. 2022-09-08 US claimed
EP-4021406-A1 COMPOSITIONS FOR SMALL MOLECULE THERAPEUTIC AGENT COMPOUNDS Delpor, Inc. (US) 2022-07-06 EP claimed
WO-2021041730-A1 COMPOSITIONS FOR SMALL MOLECULE THERAPEUTIC AGENT COMPOUNDS DELPOR, INC. (US) 2021-03-04 WO claimed
US-20210000740-A1 COMPOSITIONS FOR SMALL MOLECULE THERAPEUTIC AGENT COMPOUNDS DELPOR, INC. 2021-01-07 US claimed
EP-3758701-A1 COMPOSITIONS FOR SMALL MOLECULE THERAPEUTIC AGENT COMPOUNDS Delpor, Inc. (US) 2021-01-06 EP claimed
EP-2859069-B1 METHOD AND APPARATUS FOR TREATING PETROLEUM EQUIPMENT FERRARA MARCELLO (IT) 2020-10-14 EP claimed
EP-3515407-A1 COMPOSITIONS FOR SMALL MOLECULE THERAPEUTIC AGENT COMPOUNDS Delpor, Inc. (US) 2019-07-31 EP claimed
EP-3515408-A1 STABLE COMPOSITIONS FOR INCRETIN MIMETIC COMPOUNDS Delpor, Inc. (US) 2019-07-31 EP claimed
US-20190224322-A1 COMPOSITIONS FOR SMALL MOLECULE THERAPEUTIC AGENT COMPOUNDS DELPOR, INC. 2019-07-25 US claimed
US-20190224122-A1 STABLE COMPOSITIONS FOR INCRETIN MIMETIC COMPOUNDS NATIONAL INSTITUTES OF HEALTH 2019-07-25 US claimed
US-9732032-B2 3-aminocyclopentane carboxamide derivatives MERCK PATENT GMBH (DE) 2017-08-15 US claimed
EP-2920146-B1 3-AMINOCYCLOPENTANE CARBOXAMIDE DERIVATIVES MERCK PATENT GMBH (DE) 2016-09-28 EP claimed
US-20160264517-A1 3-AMINOCYCLOPENTANE CARBOXAMIDE DERIVATIVES MERCK PATENT GMBH (DE) 2016-09-15 US claimed
US-9328300-B2 Method, apparatus and chemical products for treating petroleum equipment FERRARA MARCELLO (IT) 2016-05-03 US claimed
EP-2920146-A1 3-AMINOCYCLOPENTANE CARBOXAMIDE DERIVATIVES Merck Patent GmbH (DE) 2015-09-23 EP claimed
EP-2859069-A1 METHOD AND APPARATUS FOR TREATING PETROLEUM EQUIPMENT Ferrara, Marcello (IT) 2015-04-15 EP claimed
WO-2014075754-A1 3-AMINOCYCLOPENTANE CARBOXAMIDE DERIVATIVES MERCK PATENT GMBH (DE) 2014-05-22 WO claimed
WO-2013156228-A1 METHOD AND APPARATUS FOR TREATING PETROLEUM EQUIPMENT FERRARA MARCELLO (IT) 2013-10-24 WO claimed
US-20130270157-A1 METHOD, APPARATUS AND CHEMICAL PRODUCTS FOR TREATING PETROLEUM EQUIPMENT FERRARA MARCELLO (IT) 2013-10-17 US claimed
WO-1995020637-A2 HYDROCARBON OIL-AQUEOUS FUEL AND ADDITIVE COMPOSITIONS MEG S.N.C. DI SCOPELLITI SOFIA & C. (IT) 1995-08-03 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160264517-A1 3-AMINOCYCLOPENTANE CARBOXAMIDE DERIVATIVES FADS1, FASN, FFAR3 ALDH1A1 1309/4885SMN1; SMN2 2863/4885SRD5A2 921/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.